CapsoVision, Inc. CV
6.37 USD -0.07 (-1.09%)
At closeNov 10, 2026, 4:01 PM EST
6.37 0.00 0.00%
After hours · Nov 10, 4:01 PM ET
6.27 Day range 6.56
4.50 52-week range 15.37
- YTD
- -40.41%
- 1 year
- +28.95%
News
defenseworld.net CapsoVision (NASDAQ:CV) Share Price Crosses Above 200 Day Moving Average – What’s Next? CapsoVision, Inc. (NASDAQ: CV - Get Free Report) passed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $6.35 and traded as high…
globenewswire.com CapsoVision to Release Third Quarter 2026 Financial Results on November 12, 2026 SARATOGA, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy…
marketbeat.com CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening CapsoVision NASDAQ: CV outlined its strategy to expand capsule endoscopy technology beyond its current small-bowel business into colon, pancreatic and esophageal cancer screening applications,…
gurufocus.com SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026 SKYRIZIÂ (risankizumab) and RINVOQÂ (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2
globenewswire.com CapsoVision to Present at the 20th Annual LD Micro Main Event SARATOGA, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy…
gurufocus.com New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease New SKYRIZIÂ (risankizumab-rzaa) and RINVOQÂ (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel DiseasePR NewswireNOR
defenseworld.net Head to Head Survey: CapsoVision (NASDAQ:CV) vs. Brainsway (NASDAQ:BWAY) CapsoVision (NASDAQ: CV - Get Free Report) and Brainsway (NASDAQ: BWAY - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two…
defenseworld.net CapsoVision (NASDAQ:CV) and NeuroPace (NASDAQ:NPCE) Critical Contrast NeuroPace (NASDAQ: NPCE - Get Free Report) and CapsoVision (NASDAQ: CV - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two…
gurufocus.com AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV CongressPR Newsw
defenseworld.net CapsoVision gets FDA clearance for AI Highlights What happened CapsoVision, Inc. (NASDAQ: CV) said AI Highlights, its AI-assisted reading tool for CapsoCam Plus, received FDA clearance on September 25, 2026. The company says it is a…
benzinga.com CapsoVision Receives FDA Clearance For Its AI Highlights Reading Tool For The CapsoCam Plus System AI Highlights is designed to support physicians in the review of small bowel capsule endoscopy studies collected from adult and pediatric patients (over two years of age) in whom the study was…
globenewswire.com CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus® AI-assisted reading tool designed to aid physician review of small bowel capsule endoscopy studies performed due to suspected bleeding using the CapsoCam Plus® system AI-assisted reading tool…
defenseworld.net CapsoVision (NASDAQ:CV) Major Shareholder Eliyahou Et Al Harari Purchases 1,757,469 Shares CapsoVision, Inc. (NASDAQ: CV - Get Free Report) major shareholder Eliyahou Et Al Harari acquired 1,757,469 shares of CapsoVision stock in a transaction that occurred on Friday, September 18th. The…
gurufocus.com AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis AbbVie Announces European Commission Approval of RINVOQÂ (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic ArthritisPR
benzinga.com CapsoVision Announces Offering Of 3,163,444 Shares Of Common Stock At A Price Of $5.69/Share, Net Proceeds Expected At $17.83M CapsoVision, Inc.3,163,444 Shares of Common Stock We are offering 3,163,444 shares of our common stock, par value $0.001 per share, under this prospectus supplement directly to a number of investors…
defenseworld.net Critical Contrast: Zimmer Biomet (NYSE:ZBH) versus CapsoVision (NASDAQ:CV) Zimmer Biomet (NYSE: ZBH - Get Free Report) and CapsoVision (NASDAQ: CV - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on…
defenseworld.net BlackRock Inc. Acquires New Shares in CapsoVision, Inc. $CV BlackRock Inc. purchased a new position in shares of CapsoVision, Inc. (NASDAQ: CV) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange…
globenewswire.com CapsoVision to Participate in Upcoming Investor Conferences SARATOGA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy…
gurufocus.com Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings [url="]Alnylam Pharmaceuticals, Inc[/url]. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology
seekingalpha.com CapsoVision, Inc. (CV) Q2 2026 Earnings Call Transcript CapsoVision, Inc. (CV) Q2 2026 Earnings Call Transcript
marketbeat.com CapsoVision Q2 Earnings Call Highlights CapsoVision NASDAQ: CV reported second-quarter revenue growth as sales of its CapsoCam Plus capsule endoscopy system increased, while the company advanced its artificial intelligence software rollout…
benzinga.com CapsoVision Q2 2026 Earnings Call Transcript CapsoVision (NASDAQ:CV) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call…
benzinga.com CapsoVision Files Prospectus For Up To $250M Offering Of Common Stock, Preferred Stock, Warrants, Rights And Units CapsoVision, Inc.$250,000,000Common StockPreferred StockWarrantsRightsUnits From time to time, we may offer to sell the securities described in this prospectus separately or together in any…
globenewswire.com CapsoVision Reports Second Quarter 2026 Financial Results SARATOGA, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Monday.
benzinga.com Transcript: CapsoVision Q1 2026 Earnings Conference Call - benzinga.com CapsoVision Q1 EPS $(0.15) Misses $(0.13) Estimate, Sales $2.792M Miss $3.188M Estimate CapsoVision (NASDAQ:CV) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 25 percent. This is a 93.98 percent increase over losses of $(2.49)…
benzinga.com Earnings Scheduled For May 14, 2026 - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com Benchmark Maintains Speculative Buy on CapsoVision, Lowers Price Target to $10 Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and lowers the price target from $14 to $10.
benzinga.com CapsoVision Q4 EPS $0.02 Beats $(0.14) Estimate, Sales $3.918M Miss $4.151M Estimate. CapsoVision (NASDAQ:CV) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.14) by 113.79 percent. This is a 100.91 percent increase over losses of $(2.20)…- benzinga.com Earnings Scheduled For March 26, 2026
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com CapsoVision Closes $14M Private Placement In Public Equity Financing CapsoVision, Inc. (the "Company") (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced the closing of a…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com Benchmark Maintains Speculative Buy on CapsoVision, Raises Price Target to $14 Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and raises the price target from $5 to $14.
benzinga.com Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session 
benzinga.com CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday 
benzinga.com Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday U.S. stock futures mixed on Tuesday, potential stocks to watch: TEN Holdings up 17%, Fonar up 24%, CapsoVision down 11%.
benzinga.com Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday 
benzinga.com Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com Why ZIM Integrated Shipping Services Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket 
benzinga.com Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com Why MindWalk Holdings Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket